News

Nelipak Laboratory Services Announces ISO/IEC 17025 Accreditation

Laboratory Services Celebrates 10th Anniversary Achieving ISO/IEC 17025 Accreditation

Clara, Ireland September 10, 2020 Nelipak® Laboratory Services (“Nelipak”), a leading provider of healthcare packaging testing for the medical device and pharmaceutical sectors, today announced that its Clara, Ireland laboratory has received ISO/IEC 17025 accreditation from the Irish National Accreditation Board (INAB).

ISO 17025 accreditation certifies that Clara, established in 2009, is a commercially independent laboratory providing testing services on packaging systems and materials. The lab provides a comprehensive range of testing services to support package testing requirements, which are necessary for product validation, used to determine causes of product failure and help to prevent potential quality issues with products.

The facility provides services for accelerated aging, transportation/distribution simulation, package/seal integrity testing, material testing and analytical testing – with all testing performed to International Standards. Nelipak advises on what testing is suitable for certain applications and meets customer requirements with fast turnaround times and accurate and professional reports.

“At Nelipak, we are committed to achieving and maintaining the highest standard of quality and service in all aspects of our laboratory testing. This commitment is underpinned by the hard work of our team resulting in achieving this accreditation,” said Paul Arthur, operations director, Nelipak. “Our team of experts is dedicated to advising, problem solving and providing consultation on all aspects of packaging regulation and standards for our customers in the medical device, pharmaceutical, packaging, life science and food industries.”

To meet growing demand for services, the lab recently expanded its climatic conditioning capacity with the addition of a large programmable ASC WZH 10 B1 CO climatic conditioning chamber. The chamber enables the lab to test packaging and products that may be exposed to a range of climatic stresses during distribution throughout the world.

To learn more about our laboratory services, click here. To speak to one of our expert team or for more information on our services contact info@nelipak.com.

###

About Nelipak® Corporation

With facilities in Cranston, RI; Whitehall, PA; Phoenix, AZ; Venray, the Netherlands; Galway, Ireland; Clara, Ireland; Derry, Northern Ireland; Elsham, United Kingdom; Humacao, Puerto Rico; and San Jose, Costa Rica, Nelipak® Healthcare Packaging designs, develops and manufactures custom packaging products that provide superior protection for medical devices and pharmaceuticals.   Nelipak® Healthcare Packaging customers consist of some of the largest and most reputable medical device and pharmaceutical companies in the world.  With over 1,400 employees worldwide, Nelipak® is focused on delivering superior quality and customer experience through world class manufacturing at each of its locations.

Nelipak® Laboratory Services is a trade name of Nelipak Corporation

Follow us on:
Twitter: www.twitter.com/nelipak1953 
LinkedIn: https://www.linkedin.com/company/nelipak
YouTube: www.youtube.com/user/nelipakhealthcare

Nelipak Marketing Contact:

Seán Egan
Director of Global Marketing
Nelipak Healthcare Packaging
+353-91-709-163
sean.egan@nelipak.com

Press Contact:

Sage Morander
SVM Public Relations
401-490-9700
sage.morander@svmpr.com

Nelipak Elsham Appoints Jonathan Smith as Sales Director of Food Packaging in the United Kingdom

Seasoned Industry Veteran Brings More Than 20 Years of Packaging Experience to the Position

Elsham, United Kingdom – August 13, 2020Nelipak® Corporation, Inc. (“Nelipak”), a global leader in rigid and flexible packaging, today announced that Jonathan Smith has joined its Elsham team as UK sales director of food packaging. In his new role, Jonathan will oversee the development and performance of sales activities within the region with the goal of maximizing profitability and establishing plans and strategies to expand the customer base and drive growth.

Nelipak has long been a leader in the medical device and pharmaceutical packaging market.  With its acquisition of Bemis in Europe last year, it has acquired a leading flexible packaging business that provides solutions for a variety of food and consumer products out of its Elsham facility.

“We are thrilled to add Jonathan’s leadership to the Nelipak sales team to guide our growing food packaging offering,” said Roger Prevot, CEO, Nelipak. “We look forward to leveraging his deep packaging experience to expand our presence in the UK market.”

Jonathan has worked in the packaging industry for more than twenty years and has a proven track record for increasing brand and product awareness and devising marketing and sales strategies that grow revenue. He comes to Nelipak from CCL Label Ltd, where he served as UK sales director for two years. Prior to that, he was the sales manager for UK/Northern Europe with Bemis.

“I am excited to join the Nelipak team at a pivotal point for the company’s food packaging business,” said Mr. Smith. “As sales director, I am eager to foster meaningful and mutually-beneficial relationships with new and existing customers in the territory.”

###

About Nelipak®

With 10 facilities in the Americas and Europe, Nelipak® Healthcare Packaging designs, develops and manufactures custom packaging products that provide superior protection for the food, medical devices and pharmaceuticals markets. Nelipak® Healthcare Packaging customers consist of some of the largest and most reputable companies in the world.  With over 1,400 employees worldwide, Nelipak® is focused on delivering superior quality and customer experience through world class manufacturing at each of its locations.

Follow us on:

LinkedIn:  https://www.linkedin.com/showcase/nelipak-elsham-

Twitter: www.twitter.com/nelipak1953 

YouTube: www.youtube.com/user/nelipakhealthcare

Nelipak Marketing Contact:
Seán Egan
Director of Global Marketing
Nelipak Healthcare Packaging
+353-91-709-163
sean.egan@nelipak.com

Press Contact: Jordan Bouclin
SVM Public Relations
401-490-9700
jordan.bouclin@svmpr.com

Nelipak Healthcare Packaging Update Statement Regarding Coronavirus (COVID-19) July 2nd, 2020

We are taking this opportunity to share with you our latest update during the current pandemic. We continue to closely monitor the situation regarding the COVID-19 Coronavirus with the safety and wellbeing of our clients and colleagues remaining our highest priority.   

Nelipak is an essential business

Due to the unprecedented nature of our current business environment, Nelipak management has taken significant steps throughout our global manufacturing network to keep production lines running as an essential business in support of our customers, supply chain partners and ultimately the patients we collectively serve.

Nelipak continues to remain open for business at all ten (10) of our facilities worldwide keeping our customers up and running with no significant supply disruptions. Our manufacturing sites are located in the United States (3 sites in Arizona, Pennsylvania, Rhode Island), the Republic of Ireland (2 sites), the United Kingdom (2 sites in Northern Ireland and England), the Netherlands, Puerto Rico, and Costa Rica.

Despite the challenges of Covid-19 we continue to make great progress on a range of new initiatives, including investments in our plants, improving quality, raising customer service levels, driving innovation and building our organization and capabilities to supply customers with both rigid and flexible packaging. 

Supply chain update

While COVID-19 has upended daily life and created economic uncertainty there are encouraging signs of recovery as doctors, dentists, clinics and hospitals globally look to resume routine appointments and elective procedures under new norms. While the timing of this recovery remains uncertain and may differ from one geography to the next, we expect to see increased demand recovery during the next few weeks.

We thank you for your support to date in reviewing demand and updating us regarding your requirements.  However, the situation continues to evolve and change with limited notice.

Our ability to seamlessly scale production to meet demand recovery will depend upon how well we are able to work together with you to proactively coordinate the ramp-up of your production needs. As you can imagine, without effective collaborative forecasting and pre-planning, Nelipak will not be able to service all customers within standard lead-times.

As we work together to get through this difficult time, our Sales and Customer Service Teams will continue to reach out to you regularly, but we also ask that you communicate to us on a regular basis about what you are seeing in your business and the market segments you serve. By working together, we can help anticipate your needs and give our respective teams and the customers we collectively serve the best chance to succeed when business ramps back up.

Nelipak COVID-19 Related Successes

Ahead of the anticipated recovery our product development and operations teams are working closely with customers onboarding new projects with design, prototyping, validation and manufacturing of flexible and rigid solutions delivering essential packaging.

Many of these projects include PPE and Added Value Service opportunities filling and packing our customer’s proprietary products used in COVID-19 related applications.

Our teams continue to work on these and other exciting projects which both help meet the challenges of COVID-19 and utilize Nelipak open capacity. We encourage you to talk to our team today to learn how we can assist with your next project.

Our approach to addressing COVID-19

From the onset of the pandemic we implemented a formal COVID-19 monitoring process led by Nelipak global executive leadership and involving a cross-functional team.  We continue to take action to promote employee and community safety in line with WHO, CDC, ECDC and local government guidelines.

We will continue to monitor the COVID-19 situation as it develops and provide updates as appropriate. The health and safety of our employees, customers, suppliers, business partners, and the patients who benefit from our products is our top priority. If we can answer any questions or be of any assistance, please do not hesitate to ask.

Contact us as info@nelipak.com.

Nelipak Healthcare Packaging Launches “Nelipak Academy” Webinar Series

Learning series to provide participants with knowledge to make informed decisions about healthcare packaging

CRANSTON, RI – May 21, 2020Nelipak Healthcare Packaging (“Nelipak”), a global leader in rigid and flexible packaging for the medical device and pharmaceutical sectors, today announced the launch of Nelipak Academy, a seven-part educational webinar series. The virtual events are geared toward quality and R&D engineers, packaging engineers, process and production engineers, and medical device OEM purchasing decision makers as a resource to arm them with the knowledge of what to consider when selecting healthcare packaging.

The free series will cover a variety of topics including automated handling trays, NeliSim, polymer basics and film properties, rigid barrier packaging design, lab testing services, and heat seal coating technology. Sessions will last approximately 45 minutes with a brief presentation followed by a question and answer period with Nelipak’s expert team.

Registration is open online for the first session:

Flexible and Rigid Forming Films Webinar
Tuesday, May 26
10 am EST/4 pm CET
Register

In the premiere session, Ann McDonagh, Nelipak’s senior product development and application engineer, will equip attendees with knowledge around form fill seal process basics, thermoforming process basics, properties of flexible and rigid materials, forming films material 101, and guidance for material selection for optimum packaging development. Ann has over 14 years of experience working in the medical packaging device sector, with a majority of her experience in pouch converting, machines and materials.

If you’re interested to know more about Nelipak Academy and the upcoming schedule, contact webinars@nelipak.com.

About Nelipak® Healthcare Packaging

With facilities in Cranston, RI; Whitehall, PA; Phoenix, AZ; Venray, the Netherlands; Galway, Ireland; Clara, Ireland; Derry, Northern Ireland; Elsham, United Kingdom; Humacao, Puerto Rico; and San Jose, Costa Rica, Nelipak® Healthcare Packaging designs, develops and manufactures custom packaging products that provide superior protection for medical devices and pharmaceuticals. Nelipak® Healthcare Packaging customers consist of some of the largest and most reputable medical device and pharmaceutical companies in the world.  With over 1,400 employees worldwide, Nelipak® is focused on delivering superior quality and customer experience through world class manufacturing at each of its locations.

Nelipak® Healthcare Packaging is a trade name of Nelipak Corporation

Follow us on:
Twitter: www.twitter.com/nelipak1953 
LinkedIn: https://www.linkedin.com/company/nelipak
YouTube: www.youtube.com/user/nelipakhealthcare


     

Nelipak Healthcare Packaging Update Statement Regarding Coronavirus (COVID-19) April 28, 2020

We are taking this opportunity to bring you the latest update on COVID-19 and Nelipak’s response to the ongoing situation. We continue to closely monitor the situation regarding the COVID-19 Coronavirus with the safety and wellbeing of our clients and colleagues remaining our highest priority. 

Nelipak is an essential business

Nelipak remains open for business at all ten (10) of our facilities worldwide with no significant supply disruptions. Because Nelipak is in the business of providing sterile barrier packaging for a variety of critical and life-sustaining healthcare applications, our business operations are considered essential and we continue operating in support of our customers and supply chain partners.   

Nelipak COVID-19 Related Successes:

In this time of immediate need we are directing product development resources and production capacity to help customers meet the emerging challenges of COVID-19.  As a result of the rapid mobilization by our product development and operations teams, we have been able to respond to changing demands in the market for medical and pharmaceutical products.

Our teams continue to demonstrate flexibility in response to the call for much needed PPE supplies.  Several of our sites in the US and Ireland have worked with customers to rapid prototype and ramp up manufacturing of much needed face shields to meet increasing market demand.

In addition to the PPE opportunities, we have redirected some of our AVS (Added Value Service) capabilities at our Clara, Ireland site to filling and packaging our customer’s proprietary products which are used in COVID-19 related applications.

Our teams continue to work on these and other exciting projects which both help meet the challenges of COVID-19 and utilize Nelipak open capacity. Talk to our team today to learn how we can assist with your next project.

Supply chain update

We continue to monitor our supply base carefully, our suppliers are communicating, with very limited exception, that the potential risk of disruption remains relatively low.

We thank you for your support to date in reviewing demand and updating us regarding your requirements.  However, as you aware, the situation continues to evolve and change with limited notice. Our production priority is to produce and deliver against the firm orders or other agreed upon planning forecasts in our systems. We would encourage you to continue to review any present and future demand for Nelipak products so that we can work with you to mitigate potential supply chain risks.

Our approach to addressing COVID-19

From the onset of the pandemic we implemented a formal COVID-19 monitoring process led by Nelipak global executive leadership and involving a cross-functional team.

We have continued to monitor the situation in the regions where our ten facilities operate including guidance issued by leading health authorities and governmental entities. In response, we have implemented best practice precautionary, preventative and preparedness measures at each of our sites including enhanced site hygiene and cleaning/sanitizing protocols, social distancing measures, site visitor restrictions, and remote work arrangements where appropriate.

We will continue to monitor the COVID-19 situation as it develops and provide updates as appropriate. The health and safety of our employees, customers, suppliers, business partners, and the patients who benefit from our products remains our top priority. If we can answer any questions or be of any assistance, please do not hesitate to ask. Contact us as info@nelipak.com.

Nelipak Represented at St. Mary’s College STEM Career Fair

Nelipak at St. Mary's STEM Career Fair

Aisling McGreanery, Product Engineer,  and Dawn Galbraith, Group Financial Controller, represented Nelipak Healthcare Packaging at the St. Mary’s College STEM Career Fair.

As a past pupil of the school,  Aisling was particularly delighted to support her alma mater and share the broad breadth of sterile barrier packaging capabilities and career opportunities Nelipak offers.

Engineers Week took place in St. Marys College between 2nd – 6th March and the team was at the STEM (Science, Technology, Engineering & Mathematics) Careers Fair.

Students from various schools from both the North and South of Ireland, including St. Mary’s (both girls and boys), from Year 10-14 rotated in groups of approx. 10 every 10 minutes or so to hear what each company had to offer in terms of STEM-related careers. Some other companies that came included AE Global, E&I Engineering and Terex.

Visual representation is key when it came to engaging with the students, hence why the team took along samples and a video demo to show exactly what Nelipak has to offer. It was a great turnout and students were very interested in the company overall. The pens also went down a treat!

Nelipak Appoints Roger Prevot as Chief Executive Officer

Cranston, RI, (October 10, 2019)Nelipak® Corporation, Inc. (“Nelipak”), a global leader in rigid and flexible packaging for the medical device and pharmaceutical sectors, announced today that Roger Prevot has been named the company’s Chief Executive Officer. Prevot, who has been Chairman of the Board of Directors since the acquisition of Nelipak (“Kohlberg”) earlier this year, brings to Nelipak an extensive track record of senior leadership experience in the packaging industry, and is a Partner of Kohlberg.  Prevot’s previous roles include President and Chief Operating Officer of Graham Packaging, Chief Executive Officer of Packaging Dynamics Corporation, Chairman of the Board of Spectrum Plastics Group and Chairman of the Board of Cadence, Inc.

Prevot stated, “I look forward to leading Nelipak into the next phase of its development as the legacy Nelipak business is integrated with the former European Healthcare Packaging business of Bemis Corporation.”

Prevot assumes this role from Michael Kelly, Nelipak’s current Chief Executive Officer. Under Kelly’s leadership, Nelipak grew both organically and via acquisition and matured into a global leader in its served markets. Having substantially completed his objective to position Nelipak for the next phase of its development, Kelly is retiring.

Kelly commented, “I am proud of the accomplishments we have achieved together at Nelipak and the recent sale to Kohlberg. Roger’s distinguished track record, together with his strong professional and personal values, make him an outstanding successor to lead Nelipak into the future. I wish Roger and the people of Nelipak much continued success in the years to come.”

Seth H. Hollander, Partner of Kohlberg, commented, “On behalf of the Board of Directors of Nelipak, I wish to sincerely thank Mike for his distinguished service to the company. Mike was instrumental in building a foundation for sustained growth at Nelipak.” Hollander continued, “As Chairman, Roger has been instrumental in the creation of the current Nelipak and its plan for transformational initiatives going forward. As a result of his vision, Nelipak is well-positioned for continued excellence in innovation and customer service as well as growth execution.”

For further information on Nelipak and its various products, please visit www.nelipak.com.

About Nelipak® Healthcare Packaging

With facilities in Cranston, RI; Whitehall, PA; Phoenix, AZ; Venray, the Netherlands; Galway, Ireland; Clara, Ireland; Derry, Northern Ireland; Elsham, United Kingdom; Humacao, Puerto Rico; and San Jose, Costa Rica, Nelipak® Healthcare Packaging designs, develops and manufactures custom packaging products that provide superior protection for medical devices and pharmaceuticals.   Nelipak® Healthcare Packaging customers consist of some of the largest and most reputable medical device and pharmaceutical companies in the world.  With over 1,400 employees worldwide, Nelipak® is focused on delivering superior quality and customer experience through world class manufacturing at each of its locations.

Nelipak® Healthcare Packaging is a trade name of Nelipak Corporation

About Kohlberg & Company, LLC

Kohlberg & Company, LLC (“Kohlberg”) is a leading private equity firm headquartered in Mount Kisco, New York. Since its inception in 1987, Kohlberg has organized eight private equity funds, through which it has raised over $7.5 billion of committed equity capital. Over its 32-year history, Kohlberg has completed 76 platform investments and nearly 200 add-on acquisitions, with an aggregate transaction value in excess of $15 billion.  For more information, please visit www.kohlberg.com.

Released by:
Seán Egan, Nelipak® Healthcare Packaging
Tel: 00 353 (0)91 709 163
Email: sean.egan@nelipak.com

Nelipak Wins 2019 Terumo Aortic Supplier Recognition Award

Nelipak Healthcare Packaging is pleased to announce we are the winner of the 2019 Terumo Aortic Supplier Recognition Award in the Innovation Category. Terumo Aortic’s annual awards recognize excellence in quality and honor those suppliers who go the extra mile during product development/launch and provide superior innovation.

Nelipak was nominated by the Terumo Aortic’s Quality Assurance department for our role in optimizing packaging of blister components to provide improved quality. We are honored to receive this recognition and proud to have worked with Terumo Aortic’s QA team on the creation of more robust specifications and to offer continued SME support throughout the process.

2019 Terumo Aortic Supplier Recognition Award

Kohlberg closes on acquisition of Bemis Healthcare Packaging Europe; Merges with Nelipak

CRANSTON (August 8th, 2019) – Nelipak® Corporation, Inc. (“Nelipak”), a leading provider of custom designed packaging for the medical device and pharmaceutical industries, announced today that Kohlberg & Company, L.L.C. (Kohlberg), a private equity firm headquartered in Mount Kisco, NY, and Nelipak’s owner, has completed the acquisition of Bemis® Healthcare Packaging Europe (Bemis®) from Amcor’s Flexible Packaging business unit. Bemis®, located in Clara (Ireland), Derry (Northern Ireland, UK), and Elsham (United Kingdom), will be merged with Nelipak, and the combined company will operate under the Nelipak® Healthcare Packaging brand.

Headquartered in Cranston, Rhode Island, Nelipak is a leading global manufacturer of custom-designed rigid healthcare packaging used for Class II and Class III medical devices, and pharma drug delivery products. The company operates strategically located cleanroom facilities meeting customers’ most stringent packaging requirements. Nelipaks’ experienced in-house design, development, prototyping, manufacturing and quality teams offer medical trays and blisters, custom built sealing machines and other value-added services.

“We are excited about the addition of the Bemis® European Healthcare Packaging business, a great organization with outstanding people and tremendous capabilities and we proudly welcome the team to Nelipak,” said Mike Kelly President and CEO of Nelipak. “We will leverage the unique capabilities of both organizations to delight our customers with innovative designs, world class quality, and excellent service. This will significantly enhance Nelipak’s capabilities with the addition of flexible packaging alternatives for our global customers.”

“Our recent acquisition of Nelipak represented a platform for growth and consolidation” commented Seth H. Hollander, Partner of Kohlberg.  “The Bemis acquisition provides a unique opportunity to create global scale and diversification across complementary product offerings.”  Roger Prevot, Operating Partner of Kohlberg, added, “This combination provides attractive opportunities for revenue growth from cross-selling and geographic expansion.  Mike and his team will be better equipped to serve the company’s customers as a comprehensive partner for their packaging needs.”

William Blair & Company served as financial advisor and Goodwin Procter LLP served as legal counsel to Amcor. Lincoln International LLC served as financial advisor and Paul, Weiss, Rifkind, Wharton & Garrison served as legal counsel to Kohlberg and Nelipak.  

About Nelipak® Healthcare Packaging

With facilities in Cranston, RI; Whitehall, PA; Phoenix, AZ; Venray, the Netherlands; Galway, Ireland; Clara, Ireland; Derry, Northern Ireland; Elsham, United Kingdom; Humacao, Puerto Rico; and San Jose, Costa Rica, Nelipak® Healthcare Packaging designs, develops and manufactures custom packaging products that provide superior protection for medical devices and pharmaceuticals.   Nelipak® Healthcare Packaging customers consist of some of the largest and most reputable medical device and pharmaceutical companies in the world.  With over 1,400 employees worldwide, Nelipak® is focused on delivering superior quality and customer experience through world class manufacturing at each of its locations.

Nelipak® Healthcare Packaging is a trade name of Nelipak Corporation

About Kohlberg & Company, LLC 

Kohlberg & Company, LLC (“Kohlberg”) is a leading private equity firm headquartered in Mount Kisco, New York. Since its inception in 1987, Kohlberg has organized eight private equity funds, through which it has raised over $7.5 billion of committed equity capital. Over its 32-year history, Kohlberg has completed 79 platform investments and nearly 200 add-on acquisitions, with an aggregate transaction value in excess of $15 billion.  For more information, please visit www.kohlberg.com.

Released by:

Seán Egan, Director of Global Marketing

Nelipak® Healthcare Packaging           

Tel: 00 353 (0)91 709 163 

Email: sean.egan@nelipak.com                    

Kohlberg & Company acquire Nelipak Healthcare Packaging

Cranston, RI, (July 2nd, 2019) – Nelipak® Corporation, Inc. (“Nelipak”), the leading provider of custom designed rigid packaging for the medical device and pharmaceutical industries, announced today that it has been acquired by Kohlberg & Company, L.L.C. (Kohlberg), a private equity firm headquartered in Mount Kisco, NY., from Mason Wells.  The business will continue to operate under the name of Nelipak® Healthcare Packaging.

Headquartered in Cranston, Rhode Island, Nelipak is the leading global manufacturer of custom-designed rigid healthcare packaging used for Class II and Class III medical devices, and pharma drug delivery products. The company operates strategically located cleanroom facilities meeting customers’ most stringent packaging requirements. Nelipaks’ experienced in-house design, development, prototyping, manufacturing and quality teams offer medical trays and blisters, surgical procedure trays, pharmaceutical handling trays, custom built sealing machines and other value-added services. With a staff of over 800, the company operates from seven production facilities, five in the Americas – located in Cranston, RI.; Whitehall, PA; Phoenix, AZ.; Humacao, Puerto Rico, San Jose, Costa Rica; two in Europe – located in Venray, the Netherlands and Galway, Ireland.

“We have accomplished a lot at Nelipak during the past six years, and we are very grateful for the support given to us by Mason Wells. Our future is very bright with Kohlberg,” said Mike Kelly, President and CEO of Nelipak. “Kohlberg is committed to investing in Nelipak to make us an even stronger organization with additional capabilities to offer our customers around the world. With our global locations, world class design team, modern cleanroom manufacturing, strong sales organization and experienced management team, Nelipak is well positioned to take advantage of growth opportunities in the market. “

“Nelipak has successfully transformed itself into a leading global player in healthcare packaging and an ideal platform for further industry consolidation,” commented Seth H. Hollander, Partner of Kohlberg.  “Our plans include leveraging Mike and his team, and their customer relationships, with sizeable, global acquisitions.”  Roger Prevot, Operating Partner of Kohlberg, added, “A business with Nelipak’s global market position represents a unique investment opportunity.  We look forward to supporting Mike and his team as they continue to execute their plan for organic and M&A-driven growth, while continuing to provide their customers with best-in-class service.”

About Nelipak® Healthcare Packaging

With facilities in Cranston, RI; Whitehall, PA; Phoenix, AZ; Venray, the Netherlands; Galway, Ireland; Humacao, Puerto Rico; and San Jose, Costa Rica, Nelipak® Healthcare Packaging designs, develops and manufactures custom thermoformed packaging products that provide superior protection for medical devices and pharmaceuticals.  The company offers medical trays and blisters, surgical procedure trays, pharmaceutical handling trays, custom built sealing machines and other value-added services.  Nelipak® Healthcare Packaging customers consist of some of the largest and most reputable medical device and pharmaceutical companies in the world.  With over 800 employees worldwide, Nelipak® is focused on delivering superior quality and customer experience through world class manufacturing at each of its locations.

Nelipak® Healthcare Packaging is a trade name of Nelipak Corporation

 

About Kohlberg & Company, LLC 

Kohlberg & Company, LLC (“Kohlberg”) is a leading private equity firm headquartered in Mount Kisco, New York. Since its inception in 1987, Kohlberg has organized eight private equity funds, through which it has raised over $7.5 billion of committed equity capital. Over its 32-year history, Kohlberg has completed 76 platform investments and nearly 200 add-on acquisitions, with an aggregate transaction value in excess of $15 billion.  For more information, please visit www.kohlberg.com.

Released by:

Seán Egan, Nelipak® Healthcare Packaging
Tel: 00 353 (0)91 709 163
Email: sean.egan@nelipak.com